X4 Pharmaceuticals, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.02 | -$0.00 | -$0.01 |
| Q2 2024 | 3 | -$0.49 | -$0.07 | -$0.17 |
| Q3 2024 | 5 | -$0.18 | -$0.12 | -$0.16 |
| Q1 2025 | 2 | -$0.16 | -$0.14 | -$0.15 |
| Q2 2025 | 1 | -$0.37 | -$0.06 | -$0.13 |
| Q3 2025 | 1 | -$0.37 | -$0.06 | -$0.13 |
| Q4 2025 | 1 | -$0.37 | -$0.06 | -$0.13 |
X4 Pharmaceuticals, Inc. Earnings Date And Information
X4 Pharmaceuticals, Inc. last posted its earnings results on Wednesday, November 13th, 2024. The company reported $-0.18 earnings per share for the quarter, missing analysts' consensus estimates of $-0.17 by $0.01. The company had revenue of 560,000 for the quarter and had revenue of 0 for the year. X4 Pharmaceuticals, Inc. has generated $-1 earnings per share over the last year ($-0.57 diluted earnings per share) and currently has a price-to-earnings ratio of -4.05. X4 Pharmaceuticals, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 13th, 2025 based on prior year's report dates.
X4 Pharmaceuticals, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/13/2024 | Q3 2024 | -$0.17 | -$0.18 | -0.01 | $1.69 M | $560,000 |
| 08/08/2024 | Q2 2024 | -$0.05 | $0.45 | 0.5 | $15.27 M | $563,000 |
| 05/07/2024 | Q1 2024 | -$0.17 | -$0.26 | -0.09 | $0 | |
| 03/21/2024 | Q4 2023 | -$0.15 | -$0.10 | 0.05 | $3.06 M | |
| 11/09/2023 | Q3 2023 | -$0.15 | -$0.01 | 0.14 | $0 | |
| 08/10/2023 | Q2 2023 | -$0.17 | -$0.33 | -0.16 | $0 | |
| 05/04/2023 | Q1 2023 | -$0.20 | -$0.38 | -0.18 | $0 | |
| 03/21/2023 | Q4 2022 | -$0.23 | -$0.24 | -0.01 | $0 | |
| 11/03/2022 | Q3 2022 | -$0.31 | -$0.29 | 0.02 | $0 | |
| 08/04/2022 | Q2 2022 | -$0.65 | -$0.60 | 0.05 | $0 | |
| 05/12/2022 | Q1 2022 | -$0.62 | -$0.65 | -0.03 | $0 | |
| 03/17/2022 | Q4 2021 | -$0.68 | -$1.04 | -0.36 | $0 | |
| 11/04/2021 | Q3 2021 | -$0.72 | -$0.76 | -0.04 | $0 | |
| 08/03/2021 | Q2 2021 | -$0.73 | -$0.74 | -0.01 | $0 | |
| 05/06/2021 | Q1 2021 | -$0.84 | -$0.90 | -0.06 | $0 | |
| 03/19/2021 | Q4 2020 | -$0.91 | $0 | |||
| 11/05/2020 | Q3 2020 | -$0.74 | -$0.87 | -0.13 | $0 | |
| 08/04/2020 | Q2 2020 | -$0.76 | $0 | |||
| 05/07/2020 | Q1 2020 | -$0.83 | -$0.56 | 0.27 | $3.00 M | |
| 03/12/2020 | Q4 2019 | -$0.76 | -$0.66 | 0.1 | $0 |
X4 Pharmaceuticals, Inc. Earnings: Frequently Asked Questions
-
When is X4 Pharmaceuticals, Inc.'s earnings date?
X4 Pharmaceuticals, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, March 13th, 2025 based off last year's report dates.
-
How can I listen to X4 Pharmaceuticals, Inc.'s earnings conference call?
The conference call for X4 Pharmaceuticals, Inc.'s latest earnings report can be listened to online.
-
How can I read X4 Pharmaceuticals, Inc.'s conference call transcript?
The conference call transcript for X4 Pharmaceuticals, Inc.'s latest earnings report can be read online.
-
How much profit does X4 Pharmaceuticals, Inc. generate each year?
X4 Pharmaceuticals, Inc. (:XFOR) has a recorded net income of $0. X4 Pharmaceuticals, Inc. has generated $-0.57 earnings per share over the last four quarters.
-
What is X4 Pharmaceuticals, Inc.'s price-to-earnings ratio?
X4 Pharmaceuticals, Inc. (:XFOR) has a price-to-earnings ratio of -4.05 and price/earnings-to-growth ratio is 0.02.
